A month ago, Michael and I were talking about the epic bull market, and I asked him where the euphoria was: Markets were rocking, but the sentiment didn’t match the gains quite yet. Sentiment can change in a hurry. It feels like the election was a spark that seems to have awoken the animal spirits. Just look at … Read more
Nov 23, 2024Ravie LakshmananCloud Security / Threat Intelligence Government agencies and non-governmental organizations in the United States have become the target of a nascent China state threat actor known as Storm-2077. The adversary, believed to be active since at least January 2024, has also conducted cyber attacks against the Defense Industrial Base (DIB), aviation, telecommunications, … Read more
Uber has come a long way since its early days as a simple ride-hailing app. Today, it’s exploring a significant move: a potential acquisition of the $20 billion travel-booking giant Expedia. This could be Uber’s largest deal ever as it aims to expand beyond transport and food delivery into the world of travel. Such a … Read more
Malicious packages on the Python Package Index (PyPI), claiming to provide API access to OpenAI’s ChatGPT and Anthropic’s Claude AI models, were discovered by Kaspersky researchers to contain the JarkaStealer infostealer malware, the cybersecurity company said in a blog post Thursday. The packages, named “gptplus” and “claudeai-eng,” were both uploaded by a user called … Read more
By David Bautz, PhD NASDAQ:FBLG READ THE FULL FBLG RESEARCH REPORT Business Update On Track to Initiate Phase 1/2 Trial in Diabetic Foot Ulcers FibroBiologics, Inc. (NASDAQ:FBLG) is on track to initiate a Phase 1/2 trial of CYWC628, a fibroblast-based spheroid product candidate, in patients suffering from diabetic foot ulcers (DFU) in the second quarter … Read more
